|
V. M. Polonskii
|
|
|
O.V.Golovenko, T.K. Korneva, T.L. Michailova, I.A. Lyagina
Place Of Antibiotics In The Schemes Of Inflammatory Intestinal Diseases Treatment (review Of Literature)
|
11-19 |
|
V.A. Bechalo, V.M. Bondarenko, E.V. Sisolyatina
Mode Of Bacteria-commensales Interaction With Immunity In Certain Syndromes Of Chronic Intestinal Inflammation
|
20-25 |
|
S.A. Alekseenko
Anisakidosis: Problems Of Diagnostics And Treatment
|
26-28 |
|
A.F. Loginov
Potential For Pantoprazole Use In The Therapy Of Gastroesophageal Reflux Disease
|
29-33 |
|
S.A. Bulgakov
The Drug Hepabene In The Therapy Of Hepatobiliary System Diseases
|
34-37 |
|
E.A. Belousova
Guidelines On Diagnostics And Treatment Of Crohn’s Disease
|
38-44 |
|
T.S. Mischurovskaya, E.A. Belousova
We Present The Results Of Clinical Assessment For Applicability Of Buscopan (hyoscine Butilbromide) In The Treatment Of Chronic Pancreatitis With Pain Syndrome. In The Study, Including 52 Patients, Buscopan Significantly Reduced The Pain Intensity In A Pe
|
45-49 |
|
S.Yu. Konanychina, O.A. Serduk, I.I. Stepanova, M.L. Kastorina
Efficacy Of Ganaton (itopride Hydrochloride) Use In The Treatment Of Patients With Functional Dyspepsia
|
50-54 |
|
S.Yu. Konanychina, O.A. Serduk, I.I. Stepanova, M.L. Kastorina
Nifuratel-based Helicobacter Pylori Eradication Scheme In Children And Adults: Evaluation Of Efficacy With The Help Of Hp-antigen Method
|
55-59 |
|
M.A. Butov, E.Yu. Karpova
Influence Of Different Variants Of Eradication Therapy On Indices Of Non-specific Colon Immunity And Microbiocenosis In Patients With Peptic Ulcer Disease
|
60-66 |
|
A.S. Potapov, N.L. Pahomovskaya, G.V. Bolynets, T.S. Chetkina
Interferon Therapy Of Chronic Viral Hepatitis In Children
|
67-71 |
|
V.A. Maximov, S.E. Buntin, V.G. Buntina
Efficacy Of Odeston In The Treatment Of Patients With Chronic Pancreatitis
|
72-74 |
|
Belousova E.A.
|
75-76 |
|
V.G. Rumyantsev
Probiotics: Prospects For Therapeutic Use In Inflammatory Intestinal Diseases
|
77-79 |
Русский
